CCN1 and chronic kidney disease: Initial clinical and therapeutic translation of the presently identified MD mechanisms found that CCN1 was specifically expressed in MD cells in the human kidney, and its expression was reduced in nondiabetic CKD based on both mRNA and protein levels (Figure 7, A and B).